Berberine (3) inhibited tumor growth via the MAPK/ERK signaling pathway in nude mice and via the p53-related signaling pathway and its downstream molecules targeting XAF1 and GADD45α expression via a mitochondria-dependent pathway [55,56]. The gene discussed is TP53; the disease is neoplasm.